Celularity Inc. Tax Withholding Paid on Stock Awards
Celularity Inc. (CELU) reported Tax Withholding Paid on Stock Awards of $193.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-04-30
- Celularity Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $3.00K, a 25.00% decline year-over-year.
- Celularity Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $78.00K, a 6.85% increase year-over-year.
- Celularity Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-06-30 was $14.00K.
- Celularity Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-03-31 was $98.00K, a 72.55% decline year-over-year.
- Celularity Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $193.00K, a 55.53% decline from fiscal 2024.
- Celularity Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $434.00K, a 329.70% increase from fiscal 2023.
- Celularity Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $101.00K, a 23.48% decline from fiscal 2022.
- Celularity Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $132.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $81.00K derived: sum of 2 quarters · filed 2026-04-30 | $95.00K derived: sum of 3 quarters · filed 2026-04-30 | $193.00K 10-K · filed 2026-04-30 |
| 2025-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $92.00K derived: sum of 2 quarters · filed 2025-11-14 | $190.00K 10-Q · filed 2025-11-14 | $194.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | $112.00K 10-Q · filed 2025-08-29 | $116.00K derived: sum of 3 quarters · filed 2026-04-30 | $189.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-03-31 | $98.00K 10-Q · filed 2025-08-29 | $102.00K derived: sum of 2 quarters · filed 2026-04-30 | $175.00K derived: sum of 3 quarters · filed 2026-04-30 | $175.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $77.00K derived: sum of 2 quarters · filed 2026-04-30 | $77.00K derived: sum of 3 quarters · filed 2026-04-30 | $434.00K 10-K · filed 2026-04-30 |
| 2024-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $73.00K derived: sum of 2 quarters · filed 2025-11-14 | $430.00K 10-Q · filed 2025-11-14 | $444.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $357.00K 10-Q · filed 2024-11-07 | $371.00K derived: sum of 3 quarters · filed 2025-08-29 | $372.00K derived: sum of 4 quarters · filed 2025-08-29 |
| 2024-03-31 | $357.00K 10-Q · filed 2025-08-29 | $371.00K derived: sum of 2 quarters · filed 2025-08-29 | $372.00K derived: sum of 3 quarters · filed 2025-08-29 | $405.00K derived: sum of 4 quarters · filed 2025-08-29 |
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | $15.00K derived: sum of 2 quarters · filed 2025-05-08 | $48.00K derived: sum of 3 quarters · filed 2025-05-08 | $101.00K 10-K · filed 2025-05-08 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | $34.00K derived: sum of 2 quarters · filed 2024-12-06 | $87.00K 10-Q · filed 2024-12-06 | |
| 2023-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $86.00K 10-Q · filed 2024-11-07 | ||
| 2023-03-31 | $53.00K 10-Q · filed 2024-10-16 | |||
| 2022-12-31 | $132.00K 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |